The rare-but-serious ones are real and worth knowing, and they stay uncommon
Unfortunately, this weight loss comes at the cost of muscle loss, and we know muscle is important to overall health," George D
Clinical trial data across the semaglutide dose range indicates that sustained therapy at higher doses can produce weight reductions of 1520% or more of starting body weight in suitable candidates over 12+ months
The biggest external factor is regulatory: compounded GLP-1 availability is in transition under FDA enforcement, and anyone starting a program in June 2026 should understand what that means for supply continuity
Early in the protocol, vials last long enough that storage becomes the limiting factor (reconstituted peptide should be used within 28 to 60 days)
FOR PEOPLE WITH OTHER CONDITIONS SOURCE: Centers for Medicare and Medicaid Services